For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole ...

Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a ...

Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma (TM), a ...

MONDAY, Dec. 8, 2025 (HealthDay News) — Discharging hospital patients early to recover at home might be key to saving rural ...

The patchwork rollout of a gene therapy exposes weaknesses in the pricing and regulatory frameworks that determine who ...

From the best ski resorts to luxury hotels with zen-inducing spas, here's your complete guide to Park City, Utah.

Patients who depend on antibody drugs often spend long hours in infusion centers. These medicines are vital for treating many ...

The Muscular Dystrophy Association (MDA) recognizes the U.S. Food and Drug Administration (FDA) approval of Amgen’s UPLIZNA ® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis ...

Elisabeth Yoder’s son, Darragh, was 15 months old in August when he developed what at first looked to his parents like hand, foot and mouth disease. The common viral infection generally clears up in ...

The Muscular Dystrophy Association (MDA) recognizes the U.S. Food and Drug Administration (FDA) approval of Amgen's UPLIZNA(R) (inebilizumab-cdon) for the treatment of generalized myasthenia gravis ...

Learn more about whether Baxter International Inc. or PROCEPT BioRobotics Corporation is a better investment based on AAII's ...

Kyverna Therapeutics stock upgraded to Strong Buy after positive phase 2 results for miv-cel in SPS and MG. Read the latest ...